Clinical Trials Directory

Trials / Completed

CompletedNCT05223907

Safety and Efficacy of Maintenance of Etomidate in General Anesthesia

Safety and Efficacy of Maintenance of Etomidate Combined With Sevoflurane in General Anesthesia: a Multi-center Randomized Controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,080 (actual)
Sponsor
Henan Provincial People's Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study was designed to use etomidate combined with sevoflurane intravenously to maintain anesthesia process under the monitoring of BIS. Propofol was used as the controls. Blood pressure and heart rate were recorded during operation. The VAS pain score was observed after surgery.To investigate whether this program can better maintain intraoperative hemodynamic stability, improve the quality of recovery, and reduce the incidence of postoperative adverse reactions.

Conditions

Interventions

TypeNameDescription
DRUGEtomidateEtomidate will be used for general anesthesia
DRUGPropofolPropofol will be used for general anesthesia

Timeline

Start date
2021-05-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2022-02-04
Last updated
2024-06-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05223907. Inclusion in this directory is not an endorsement.

Safety and Efficacy of Maintenance of Etomidate in General Anesthesia (NCT05223907) · Clinical Trials Directory